Cover Image
Market Research Report
Product code 
1097464

Global Human Lyophilized Rabies Vaccine Market Insights, Forecast to 2028

Published: | QYResearch | 112 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Human Lyophilized Rabies Vaccine Market Insights, Forecast to 2028
Published: July 7, 2022
QYResearch
Content info: 112 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

This research report focuses on the Human Lyophilized Rabies Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Human Lyophilized Rabies Vaccine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Human Lyophilized Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Pre-Exposure Vaccine
    • 1.2.3 Post-Exposure Vaccine
  • 1.3 Market by Application
    • 1.3.1 Global Human Lyophilized Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Children
    • 1.3.3 Adults
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Human Lyophilized Rabies Vaccine Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Human Lyophilized Rabies Vaccine Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Human Lyophilized Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Human Lyophilized Rabies Vaccine Sales by Region
    • 2.4.1 Global Human Lyophilized Rabies Vaccine Sales by Region (2017-2022)
    • 2.4.2 Global Sales Human Lyophilized Rabies Vaccine by Region (2023-2028)
  • 2.5 Global Human Lyophilized Rabies Vaccine Revenue by Region
    • 2.5.1 Global Human Lyophilized Rabies Vaccine Revenue by Region (2017-2022)
    • 2.5.2 Global Human Lyophilized Rabies Vaccine Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Human Lyophilized Rabies Vaccine Sales by Manufacturers
    • 3.1.1 Global Top Human Lyophilized Rabies Vaccine Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Human Lyophilized Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Lyophilized Rabies Vaccine in 2021
  • 3.2 Global Human Lyophilized Rabies Vaccine Revenue by Manufacturers
    • 3.2.1 Global Human Lyophilized Rabies Vaccine Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Human Lyophilized Rabies Vaccine Revenue in 2021
  • 3.3 Global Human Lyophilized Rabies Vaccine Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Human Lyophilized Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Human Lyophilized Rabies Vaccine Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Human Lyophilized Rabies Vaccine Sales by Type
    • 4.1.1 Global Human Lyophilized Rabies Vaccine Historical Sales by Type (2017-2022)
    • 4.1.2 Global Human Lyophilized Rabies Vaccine Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • 4.2 Global Human Lyophilized Rabies Vaccine Revenue by Type
    • 4.2.1 Global Human Lyophilized Rabies Vaccine Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Human Lyophilized Rabies Vaccine Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • 4.3 Global Human Lyophilized Rabies Vaccine Price by Type
    • 4.3.1 Global Human Lyophilized Rabies Vaccine Price by Type (2017-2022)
    • 4.3.2 Global Human Lyophilized Rabies Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Human Lyophilized Rabies Vaccine Sales by Application
    • 5.1.1 Global Human Lyophilized Rabies Vaccine Historical Sales by Application (2017-2022)
    • 5.1.2 Global Human Lyophilized Rabies Vaccine Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • 5.2 Global Human Lyophilized Rabies Vaccine Revenue by Application
    • 5.2.1 Global Human Lyophilized Rabies Vaccine Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Human Lyophilized Rabies Vaccine Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • 5.3 Global Human Lyophilized Rabies Vaccine Price by Application
    • 5.3.1 Global Human Lyophilized Rabies Vaccine Price by Application (2017-2022)
    • 5.3.2 Global Human Lyophilized Rabies Vaccine Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Human Lyophilized Rabies Vaccine Market Size by Type
    • 6.1.1 North America Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 6.1.2 North America Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 6.2 North America Human Lyophilized Rabies Vaccine Market Size by Application
    • 6.2.1 North America Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 6.2.2 North America Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 6.3 North America Human Lyophilized Rabies Vaccine Market Size by Country
    • 6.3.1 North America Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 6.3.2 North America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Human Lyophilized Rabies Vaccine Market Size by Type
    • 7.1.1 Europe Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 7.1.2 Europe Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 7.2 Europe Human Lyophilized Rabies Vaccine Market Size by Application
    • 7.2.1 Europe Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 7.2.2 Europe Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 7.3 Europe Human Lyophilized Rabies Vaccine Market Size by Country
    • 7.3.1 Europe Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 7.3.2 Europe Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Human Lyophilized Rabies Vaccine Market Size by Type
    • 8.1.1 Asia Pacific Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Human Lyophilized Rabies Vaccine Market Size by Application
    • 8.2.1 Asia Pacific Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Human Lyophilized Rabies Vaccine Market Size by Region
    • 8.3.1 Asia Pacific Human Lyophilized Rabies Vaccine Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Human Lyophilized Rabies Vaccine Market Size by Type
    • 9.1.1 Latin America Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 9.1.2 Latin America Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 9.2 Latin America Human Lyophilized Rabies Vaccine Market Size by Application
    • 9.2.1 Latin America Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 9.2.2 Latin America Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 9.3 Latin America Human Lyophilized Rabies Vaccine Market Size by Country
    • 9.3.1 Latin America Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 9.3.2 Latin America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Human Lyophilized Rabies Vaccine Market Size by Type
    • 10.1.1 Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Human Lyophilized Rabies Vaccine Market Size by Application
    • 10.2.1 Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Human Lyophilized Rabies Vaccine Market Size by Country
    • 10.3.1 Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Bharat Biotech
    • 11.1.1 Bharat Biotech Corporation Information
    • 11.1.2 Bharat Biotech Overview
    • 11.1.3 Bharat Biotech Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Bharat Biotech Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bharat Biotech Recent Developments
  • 11.2 Sanofi-Pasteur
    • 11.2.1 Sanofi-Pasteur Corporation Information
    • 11.2.2 Sanofi-Pasteur Overview
    • 11.2.3 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Sanofi-Pasteur Recent Developments
  • 11.3 Serum Institute of India
    • 11.3.1 Serum Institute of India Corporation Information
    • 11.3.2 Serum Institute of India Overview
    • 11.3.3 Serum Institute of India Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Serum Institute of India Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Serum Institute of India Recent Developments
  • 11.4 Bio-Med
    • 11.4.1 Bio-Med Corporation Information
    • 11.4.2 Bio-Med Overview
    • 11.4.3 Bio-Med Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Bio-Med Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Bio-Med Recent Developments
  • 11.5 Novartis Pharmaceuticals
    • 11.5.1 Novartis Pharmaceuticals Corporation Information
    • 11.5.2 Novartis Pharmaceuticals Overview
    • 11.5.3 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novartis Pharmaceuticals Recent Developments
  • 11.6 Bavarian Nordic
    • 11.6.1 Bavarian Nordic Corporation Information
    • 11.6.2 Bavarian Nordic Overview
    • 11.6.3 Bavarian Nordic Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Bavarian Nordic Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Bavarian Nordic Recent Developments
  • 11.7 Chengdu Kanghua Biological
    • 11.7.1 Chengdu Kanghua Biological Corporation Information
    • 11.7.2 Chengdu Kanghua Biological Overview
    • 11.7.3 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Chengdu Kanghua Biological Recent Developments
  • 11.8 Changchun Zhuoyi Biological
    • 11.8.1 Changchun Zhuoyi Biological Corporation Information
    • 11.8.2 Changchun Zhuoyi Biological Overview
    • 11.8.3 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Changchun Zhuoyi Biological Recent Developments
  • 11.9 Liaoning Chengda Biotech
    • 11.9.1 Liaoning Chengda Biotech Corporation Information
    • 11.9.2 Liaoning Chengda Biotech Overview
    • 11.9.3 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Liaoning Chengda Biotech Recent Developments
  • 11.10 Liaoning Yisheng Biopharma
    • 11.10.1 Liaoning Yisheng Biopharma Corporation Information
    • 11.10.2 Liaoning Yisheng Biopharma Overview
    • 11.10.3 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Liaoning Yisheng Biopharma Recent Developments
  • 11.11 Beijing Minhai Biological
    • 11.11.1 Beijing Minhai Biological Corporation Information
    • 11.11.2 Beijing Minhai Biological Overview
    • 11.11.3 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Beijing Minhai Biological Recent Developments
  • 11.12 Shenzhen Weiguang
    • 11.12.1 Shenzhen Weiguang Corporation Information
    • 11.12.2 Shenzhen Weiguang Overview
    • 11.12.3 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Shenzhen Weiguang Recent Developments
  • 11.13 Ningbo Rongan Biological
    • 11.13.1 Ningbo Rongan Biological Corporation Information
    • 11.13.2 Ningbo Rongan Biological Overview
    • 11.13.3 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Ningbo Rongan Biological Recent Developments
  • 11.14 Guangzhou Promise Biological
    • 11.14.1 Guangzhou Promise Biological Corporation Information
    • 11.14.2 Guangzhou Promise Biological Overview
    • 11.14.3 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Guangzhou Promise Biological Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Human Lyophilized Rabies Vaccine Industry Chain Analysis
  • 12.2 Human Lyophilized Rabies Vaccine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Human Lyophilized Rabies Vaccine Production Mode & Process
  • 12.4 Human Lyophilized Rabies Vaccine Sales and Marketing
    • 12.4.1 Human Lyophilized Rabies Vaccine Sales Channels
    • 12.4.2 Human Lyophilized Rabies Vaccine Distributors
  • 12.5 Human Lyophilized Rabies Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Human Lyophilized Rabies Vaccine Industry Trends
  • 13.2 Human Lyophilized Rabies Vaccine Market Drivers
  • 13.3 Human Lyophilized Rabies Vaccine Market Challenges
  • 13.4 Human Lyophilized Rabies Vaccine Market Restraints

14 Key Findings in The Global Human Lyophilized Rabies Vaccine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Human Lyophilized Rabies Vaccine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Human Lyophilized Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Pre-Exposure Vaccine
    • 1.2.3 Post-Exposure Vaccine
  • 1.3 Market by Application
    • 1.3.1 Global Human Lyophilized Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Children
    • 1.3.3 Adults
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Human Lyophilized Rabies Vaccine Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Human Lyophilized Rabies Vaccine Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Human Lyophilized Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Human Lyophilized Rabies Vaccine Sales by Region
    • 2.4.1 Global Human Lyophilized Rabies Vaccine Sales by Region (2017-2022)
    • 2.4.2 Global Sales Human Lyophilized Rabies Vaccine by Region (2023-2028)
  • 2.5 Global Human Lyophilized Rabies Vaccine Revenue by Region
    • 2.5.1 Global Human Lyophilized Rabies Vaccine Revenue by Region (2017-2022)
    • 2.5.2 Global Human Lyophilized Rabies Vaccine Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Human Lyophilized Rabies Vaccine Sales by Manufacturers
    • 3.1.1 Global Top Human Lyophilized Rabies Vaccine Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Human Lyophilized Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Lyophilized Rabies Vaccine in 2021
  • 3.2 Global Human Lyophilized Rabies Vaccine Revenue by Manufacturers
    • 3.2.1 Global Human Lyophilized Rabies Vaccine Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Human Lyophilized Rabies Vaccine Revenue in 2021
  • 3.3 Global Human Lyophilized Rabies Vaccine Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Human Lyophilized Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Human Lyophilized Rabies Vaccine Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Human Lyophilized Rabies Vaccine Sales by Type
    • 4.1.1 Global Human Lyophilized Rabies Vaccine Historical Sales by Type (2017-2022)
    • 4.1.2 Global Human Lyophilized Rabies Vaccine Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • 4.2 Global Human Lyophilized Rabies Vaccine Revenue by Type
    • 4.2.1 Global Human Lyophilized Rabies Vaccine Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Human Lyophilized Rabies Vaccine Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • 4.3 Global Human Lyophilized Rabies Vaccine Price by Type
    • 4.3.1 Global Human Lyophilized Rabies Vaccine Price by Type (2017-2022)
    • 4.3.2 Global Human Lyophilized Rabies Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Human Lyophilized Rabies Vaccine Sales by Application
    • 5.1.1 Global Human Lyophilized Rabies Vaccine Historical Sales by Application (2017-2022)
    • 5.1.2 Global Human Lyophilized Rabies Vaccine Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • 5.2 Global Human Lyophilized Rabies Vaccine Revenue by Application
    • 5.2.1 Global Human Lyophilized Rabies Vaccine Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Human Lyophilized Rabies Vaccine Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • 5.3 Global Human Lyophilized Rabies Vaccine Price by Application
    • 5.3.1 Global Human Lyophilized Rabies Vaccine Price by Application (2017-2022)
    • 5.3.2 Global Human Lyophilized Rabies Vaccine Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Human Lyophilized Rabies Vaccine Market Size by Type
    • 6.1.1 North America Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 6.1.2 North America Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 6.2 North America Human Lyophilized Rabies Vaccine Market Size by Application
    • 6.2.1 North America Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 6.2.2 North America Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 6.3 North America Human Lyophilized Rabies Vaccine Market Size by Country
    • 6.3.1 North America Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 6.3.2 North America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Human Lyophilized Rabies Vaccine Market Size by Type
    • 7.1.1 Europe Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 7.1.2 Europe Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 7.2 Europe Human Lyophilized Rabies Vaccine Market Size by Application
    • 7.2.1 Europe Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 7.2.2 Europe Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 7.3 Europe Human Lyophilized Rabies Vaccine Market Size by Country
    • 7.3.1 Europe Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 7.3.2 Europe Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Human Lyophilized Rabies Vaccine Market Size by Type
    • 8.1.1 Asia Pacific Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Human Lyophilized Rabies Vaccine Market Size by Application
    • 8.2.1 Asia Pacific Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Human Lyophilized Rabies Vaccine Market Size by Region
    • 8.3.1 Asia Pacific Human Lyophilized Rabies Vaccine Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Human Lyophilized Rabies Vaccine Market Size by Type
    • 9.1.1 Latin America Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 9.1.2 Latin America Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 9.2 Latin America Human Lyophilized Rabies Vaccine Market Size by Application
    • 9.2.1 Latin America Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 9.2.2 Latin America Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 9.3 Latin America Human Lyophilized Rabies Vaccine Market Size by Country
    • 9.3.1 Latin America Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 9.3.2 Latin America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Human Lyophilized Rabies Vaccine Market Size by Type
    • 10.1.1 Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Human Lyophilized Rabies Vaccine Market Size by Application
    • 10.2.1 Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Human Lyophilized Rabies Vaccine Market Size by Country
    • 10.3.1 Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Bharat Biotech
    • 11.1.1 Bharat Biotech Corporation Information
    • 11.1.2 Bharat Biotech Overview
    • 11.1.3 Bharat Biotech Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Bharat Biotech Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bharat Biotech Recent Developments
  • 11.2 Sanofi-Pasteur
    • 11.2.1 Sanofi-Pasteur Corporation Information
    • 11.2.2 Sanofi-Pasteur Overview
    • 11.2.3 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Sanofi-Pasteur Recent Developments
  • 11.3 Serum Institute of India
    • 11.3.1 Serum Institute of India Corporation Information
    • 11.3.2 Serum Institute of India Overview
    • 11.3.3 Serum Institute of India Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Serum Institute of India Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Serum Institute of India Recent Developments
  • 11.4 Bio-Med
    • 11.4.1 Bio-Med Corporation Information
    • 11.4.2 Bio-Med Overview
    • 11.4.3 Bio-Med Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Bio-Med Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Bio-Med Recent Developments
  • 11.5 Novartis Pharmaceuticals
    • 11.5.1 Novartis Pharmaceuticals Corporation Information
    • 11.5.2 Novartis Pharmaceuticals Overview
    • 11.5.3 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novartis Pharmaceuticals Recent Developments
  • 11.6 Bavarian Nordic
    • 11.6.1 Bavarian Nordic Corporation Information
    • 11.6.2 Bavarian Nordic Overview
    • 11.6.3 Bavarian Nordic Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Bavarian Nordic Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Bavarian Nordic Recent Developments
  • 11.7 Chengdu Kanghua Biological
    • 11.7.1 Chengdu Kanghua Biological Corporation Information
    • 11.7.2 Chengdu Kanghua Biological Overview
    • 11.7.3 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Chengdu Kanghua Biological Recent Developments
  • 11.8 Changchun Zhuoyi Biological
    • 11.8.1 Changchun Zhuoyi Biological Corporation Information
    • 11.8.2 Changchun Zhuoyi Biological Overview
    • 11.8.3 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Changchun Zhuoyi Biological Recent Developments
  • 11.9 Liaoning Chengda Biotech
    • 11.9.1 Liaoning Chengda Biotech Corporation Information
    • 11.9.2 Liaoning Chengda Biotech Overview
    • 11.9.3 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Liaoning Chengda Biotech Recent Developments
  • 11.10 Liaoning Yisheng Biopharma
    • 11.10.1 Liaoning Yisheng Biopharma Corporation Information
    • 11.10.2 Liaoning Yisheng Biopharma Overview
    • 11.10.3 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Liaoning Yisheng Biopharma Recent Developments
  • 11.11 Beijing Minhai Biological
    • 11.11.1 Beijing Minhai Biological Corporation Information
    • 11.11.2 Beijing Minhai Biological Overview
    • 11.11.3 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Beijing Minhai Biological Recent Developments
  • 11.12 Shenzhen Weiguang
    • 11.12.1 Shenzhen Weiguang Corporation Information
    • 11.12.2 Shenzhen Weiguang Overview
    • 11.12.3 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Shenzhen Weiguang Recent Developments
  • 11.13 Ningbo Rongan Biological
    • 11.13.1 Ningbo Rongan Biological Corporation Information
    • 11.13.2 Ningbo Rongan Biological Overview
    • 11.13.3 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Ningbo Rongan Biological Recent Developments
  • 11.14 Guangzhou Promise Biological
    • 11.14.1 Guangzhou Promise Biological Corporation Information
    • 11.14.2 Guangzhou Promise Biological Overview
    • 11.14.3 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Guangzhou Promise Biological Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Human Lyophilized Rabies Vaccine Industry Chain Analysis
  • 12.2 Human Lyophilized Rabies Vaccine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Human Lyophilized Rabies Vaccine Production Mode & Process
  • 12.4 Human Lyophilized Rabies Vaccine Sales and Marketing
    • 12.4.1 Human Lyophilized Rabies Vaccine Sales Channels
    • 12.4.2 Human Lyophilized Rabies Vaccine Distributors
  • 12.5 Human Lyophilized Rabies Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Human Lyophilized Rabies Vaccine Industry Trends
  • 13.2 Human Lyophilized Rabies Vaccine Market Drivers
  • 13.3 Human Lyophilized Rabies Vaccine Market Challenges
  • 13.4 Human Lyophilized Rabies Vaccine Market Restraints

14 Key Findings in The Global Human Lyophilized Rabies Vaccine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

  • Table 1. Global Human Lyophilized Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Pre-Exposure Vaccine
  • Table 3. Major Manufacturers of Post-Exposure Vaccine
  • Table 4. Global Human Lyophilized Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Human Lyophilized Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Human Lyophilized Rabies Vaccine Sales by Region (2017-2022) & (K Units)
  • Table 7. Global Human Lyophilized Rabies Vaccine Sales Market Share by Region (2017-2022)
  • Table 8. Global Human Lyophilized Rabies Vaccine Sales by Region (2023-2028) & (K Units)
  • Table 9. Global Human Lyophilized Rabies Vaccine Sales Market Share by Region (2023-2028)
  • Table 10. Global Human Lyophilized Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Region (2017-2022)
  • Table 12. Global Human Lyophilized Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Region (2023-2028)
  • Table 14. Global Human Lyophilized Rabies Vaccine Sales by Manufacturers (2017-2022) & (K Units)
  • Table 15. Global Human Lyophilized Rabies Vaccine Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Human Lyophilized Rabies Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Human Lyophilized Rabies Vaccine Revenue Share by Manufacturers (2017-2022)
  • Table 18. Human Lyophilized Rabies Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 19. Global Human Lyophilized Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Human Lyophilized Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Lyophilized Rabies Vaccine as of 2021)
  • Table 21. Human Lyophilized Rabies Vaccine Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Human Lyophilized Rabies Vaccine Product Offered
  • Table 23. Date of Manufacturers Enter into Human Lyophilized Rabies Vaccine Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 26. Global Human Lyophilized Rabies Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 27. Global Human Lyophilized Rabies Vaccine Sales Share by Type (2017-2022)
  • Table 28. Global Human Lyophilized Rabies Vaccine Sales Share by Type (2023-2028)
  • Table 29. Global Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Human Lyophilized Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Human Lyophilized Rabies Vaccine Revenue Share by Type (2017-2022)
  • Table 32. Global Human Lyophilized Rabies Vaccine Revenue Share by Type (2023-2028)
  • Table 33. Human Lyophilized Rabies Vaccine Price by Type (2017-2022) & (US$/Unit)
  • Table 34. Global Human Lyophilized Rabies Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 35. Global Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 36. Global Human Lyophilized Rabies Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 37. Global Human Lyophilized Rabies Vaccine Sales Share by Application (2017-2022)
  • Table 38. Global Human Lyophilized Rabies Vaccine Sales Share by Application (2023-2028)
  • Table 39. Global Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Human Lyophilized Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Human Lyophilized Rabies Vaccine Revenue Share by Application (2017-2022)
  • Table 42. Global Human Lyophilized Rabies Vaccine Revenue Share by Application (2023-2028)
  • Table 43. Human Lyophilized Rabies Vaccine Price by Application (2017-2022) & (US$/Unit)
  • Table 44. Global Human Lyophilized Rabies Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 45. North America Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 46. North America Human Lyophilized Rabies Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 47. North America Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Human Lyophilized Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 50. North America Human Lyophilized Rabies Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 51. North America Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Human Lyophilized Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 54. North America Human Lyophilized Rabies Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 55. North America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Human Lyophilized Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 58. Europe Human Lyophilized Rabies Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 59. Europe Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Human Lyophilized Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 62. Europe Human Lyophilized Rabies Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 63. Europe Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Human Lyophilized Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 66. Europe Human Lyophilized Rabies Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 67. Europe Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Human Lyophilized Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 70. Asia Pacific Human Lyophilized Rabies Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 71. Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 74. Asia Pacific Human Lyophilized Rabies Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 75. Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Human Lyophilized Rabies Vaccine Sales by Region (2017-2022) & (K Units)
  • Table 78. Asia Pacific Human Lyophilized Rabies Vaccine Sales by Region (2023-2028) & (K Units)
  • Table 79. Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Human Lyophilized Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 82. Latin America Human Lyophilized Rabies Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 83. Latin America Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Human Lyophilized Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 86. Latin America Human Lyophilized Rabies Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 87. Latin America Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Human Lyophilized Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 90. Latin America Human Lyophilized Rabies Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 91. Latin America Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Human Lyophilized Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
  • Table 94. Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Type (2023-2028) & (K Units)
  • Table 95. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
  • Table 98. Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Application (2023-2028) & (K Units)
  • Table 99. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
  • Table 102. Middle East and Africa Human Lyophilized Rabies Vaccine Sales by Country (2023-2028) & (K Units)
  • Table 103. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. Bharat Biotech Corporation Information
  • Table 106. Bharat Biotech Description and Major Businesses
  • Table 107. Bharat Biotech Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 108. Bharat Biotech Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. Bharat Biotech Recent Developments
  • Table 110. Sanofi-Pasteur Corporation Information
  • Table 111. Sanofi-Pasteur Description and Major Businesses
  • Table 112. Sanofi-Pasteur Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 113. Sanofi-Pasteur Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Sanofi-Pasteur Recent Developments
  • Table 115. Serum Institute of India Corporation Information
  • Table 116. Serum Institute of India Description and Major Businesses
  • Table 117. Serum Institute of India Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 118. Serum Institute of India Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Serum Institute of India Recent Developments
  • Table 120. Bio-Med Corporation Information
  • Table 121. Bio-Med Description and Major Businesses
  • Table 122. Bio-Med Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 123. Bio-Med Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Bio-Med Recent Developments
  • Table 125. Novartis Pharmaceuticals Corporation Information
  • Table 126. Novartis Pharmaceuticals Description and Major Businesses
  • Table 127. Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 128. Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Novartis Pharmaceuticals Recent Developments
  • Table 130. Bavarian Nordic Corporation Information
  • Table 131. Bavarian Nordic Description and Major Businesses
  • Table 132. Bavarian Nordic Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 133. Bavarian Nordic Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Bavarian Nordic Recent Developments
  • Table 135. Chengdu Kanghua Biological Corporation Information
  • Table 136. Chengdu Kanghua Biological Description and Major Businesses
  • Table 137. Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 138. Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Chengdu Kanghua Biological Recent Developments
  • Table 140. Changchun Zhuoyi Biological Corporation Information
  • Table 141. Changchun Zhuoyi Biological Description and Major Businesses
  • Table 142. Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 143. Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. Changchun Zhuoyi Biological Recent Developments
  • Table 145. Liaoning Chengda Biotech Corporation Information
  • Table 146. Liaoning Chengda Biotech Description and Major Businesses
  • Table 147. Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 148. Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Liaoning Chengda Biotech Recent Developments
  • Table 150. Liaoning Yisheng Biopharma Corporation Information
  • Table 151. Liaoning Yisheng Biopharma Description and Major Businesses
  • Table 152. Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 153. Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. Liaoning Yisheng Biopharma Recent Developments
  • Table 155. Beijing Minhai Biological Corporation Information
  • Table 156. Beijing Minhai Biological Description and Major Businesses
  • Table 157. Beijing Minhai Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 158. Beijing Minhai Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Beijing Minhai Biological Recent Developments
  • Table 160. Shenzhen Weiguang Corporation Information
  • Table 161. Shenzhen Weiguang Description and Major Businesses
  • Table 162. Shenzhen Weiguang Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 163. Shenzhen Weiguang Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Shenzhen Weiguang Recent Developments
  • Table 165. Ningbo Rongan Biological Corporation Information
  • Table 166. Ningbo Rongan Biological Description and Major Businesses
  • Table 167. Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 168. Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 169. Ningbo Rongan Biological Recent Developments
  • Table 170. Guangzhou Promise Biological Corporation Information
  • Table 171. Guangzhou Promise Biological Description and Major Businesses
  • Table 172. Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 173. Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 174. Guangzhou Promise Biological Recent Developments
  • Table 175. Key Raw Materials Lists
  • Table 176. Raw Materials Key Suppliers Lists
  • Table 177. Human Lyophilized Rabies Vaccine Distributors List
  • Table 178. Human Lyophilized Rabies Vaccine Customers List
  • Table 179. Human Lyophilized Rabies Vaccine Market Trends
  • Table 180. Human Lyophilized Rabies Vaccine Market Drivers
  • Table 181. Human Lyophilized Rabies Vaccine Market Challenges
  • Table 182. Human Lyophilized Rabies Vaccine Market Restraints
  • Table 183. Research Programs/Design for This Report
  • Table 184. Key Data Information from Secondary Sources
  • Table 185. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Human Lyophilized Rabies Vaccine Product Picture
  • Figure 3. Global Human Lyophilized Rabies Vaccine Market Share by Type in 2021 & 2028
  • Figure 3. Pre-Exposure Vaccine Product Picture
  • Figure 4. Post-Exposure Vaccine Product Picture
  • Figure 5. Global Human Lyophilized Rabies Vaccine Market Share by Application in 2021 & 2028
  • Figure 6. Children
  • Figure 7. Adults
  • Figure 8. Human Lyophilized Rabies Vaccine Report Years Considered
  • Figure 9. Global Human Lyophilized Rabies Vaccine Sales 2017-2028 (K Units)
  • Figure 10. Global Human Lyophilized Rabies Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Human Lyophilized Rabies Vaccine Revenue 2017-2028 (US$ Million)
  • Figure 12. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 13. Global Human Lyophilized Rabies Vaccine Sales Market Share by Region (2017-2022)
  • Figure 14. Global Human Lyophilized Rabies Vaccine Sales Market Share by Region (2023-2028)
  • Figure 15. North America Human Lyophilized Rabies Vaccine Sales YoY (2017-2028) & (K Units)
  • Figure 16. North America Human Lyophilized Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 17. Europe Human Lyophilized Rabies Vaccine Sales YoY (2017-2028) & (K Units)
  • Figure 18. Europe Human Lyophilized Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 19. Asia-Pacific Human Lyophilized Rabies Vaccine Sales YoY (2017-2028) & (K Units)
  • Figure 20. Asia-Pacific Human Lyophilized Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Latin America Human Lyophilized Rabies Vaccine Sales YoY (2017-2028) & (K Units)
  • Figure 22. Latin America Human Lyophilized Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Middle East & Africa Human Lyophilized Rabies Vaccine Sales YoY (2017-2028) & (K Units)
  • Figure 24. Middle East & Africa Human Lyophilized Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. The Human Lyophilized Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 26. The Top 5 and 10 Largest Manufacturers of Human Lyophilized Rabies Vaccine in the World: Market Share by Human Lyophilized Rabies Vaccine Revenue in 2021
  • Figure 27. Global Human Lyophilized Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 28. Global Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • Figure 29. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 30. Global Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • Figure 31. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 32. North America Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • Figure 33. North America Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 34. North America Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • Figure 35. North America Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 36. North America Human Lyophilized Rabies Vaccine Sales Share by Country (2017-2028)
  • Figure 37. North America Human Lyophilized Rabies Vaccine Revenue Share by Country (2017-2028)
  • Figure 38. United States Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 39. Canada Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 40. Europe Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • Figure 41. Europe Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 42. Europe Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • Figure 43. Europe Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 44. Europe Human Lyophilized Rabies Vaccine Sales Share by Country (2017-2028)
  • Figure 45. Europe Human Lyophilized Rabies Vaccine Revenue Share by Country (2017-2028)
  • Figure 46. Germany Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 47. France Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 48. U.K. Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 49. Italy Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 50. Russia Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 51. Asia Pacific Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • Figure 52. Asia Pacific Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • Figure 54. Asia Pacific Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Human Lyophilized Rabies Vaccine Sales Share by Region (2017-2028)
  • Figure 56. Asia Pacific Human Lyophilized Rabies Vaccine Revenue Share by Region (2017-2028)
  • Figure 57. China Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 58. Japan Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 59. South Korea Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 60. India Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 61. Australia Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 62. China Taiwan Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 63. Indonesia Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 64. Thailand Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 65. Malaysia Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 66. Latin America Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • Figure 67. Latin America Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 68. Latin America Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • Figure 69. Latin America Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 70. Latin America Human Lyophilized Rabies Vaccine Sales Share by Country (2017-2028)
  • Figure 71. Latin America Human Lyophilized Rabies Vaccine Revenue Share by Country (2017-2028)
  • Figure 72. Mexico Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 73. Brazil Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 74. Argentina Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 75. Middle East and Africa Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2028)
  • Figure 76. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 77. Middle East and Africa Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2028)
  • Figure 78. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 79. Middle East and Africa Human Lyophilized Rabies Vaccine Sales Share by Country (2017-2028)
  • Figure 80. Middle East and Africa Human Lyophilized Rabies Vaccine Revenue Share by Country (2017-2028)
  • Figure 81. Turkey Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 82. Saudi Arabia Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 83. UAE Human Lyophilized Rabies Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 84. Human Lyophilized Rabies Vaccine Value Chain
  • Figure 85. Human Lyophilized Rabies Vaccine Production Process
  • Figure 86. Channels of Distribution
  • Figure 87. Distributors Profiles
  • Figure 88. Bottom-up and Top-down Approaches for This Report
  • Figure 89. Data Triangulation
  • Figure 90. Key Executives Interviewed